| Non-COPD (N = 8) | COPD (N = 36) | Overall (N = 44) | p value* |
---|---|---|---|---|
Gender, Male (%) | 8 (100) | 34 (94.4) | 42 (95.5) | 1.00 |
Age, median (IQR) | 68.5 (6) | 67 (9) | 67 (9) | 0.953 |
Race, Caucasian white (%) | 7 (87.5) | 34 (94.4) | 41 (93.2) | 0.461 |
Diabetes, Yes (%) | 1 (12.5) | 3 (8.3) | 4 (9.1) | 0.566 |
Gastroesophageal reflux disease, Yes (%) | 4 (50) | 17 (47.2) | 21 (47.7) | 1.00 |
COPD Severity (%) | Â | Â | Â | Â |
 Mild | 0 (0) | 20 (55.6) |  |  |
 Moderate | 0 (0) | 14 (38.9) |  |  |
 Severe | 0 (0) | 2 (5.6) |  |  |
FEV1% predicted, median (IQR) | 91.65 (25.45) | 80.25 (20.75) | 82 (20.25) | 0.038 |
Inhaled corticosteroids, Yes (%) | 0 (0) | 2 (5.6) | 2 (4.5) | 1.00 |
Pack-years of smoking, median (IQR)a | 25 (35.5) | 49.5 (21.25) | 46.5 (30) | 0.018 |
Current tobacco use, Yes (%) | 1 (12.5) | 4 (11.1) | 5 (11.4) | 1.00 |
Current alcohol use, Yes (%) | 2 (25) | 24 (66.7) | 26 (59.1) | 0.048 |
Last dental visit ≤ to 6 months (%)b | 3 (42.9) | 12 (44.4) | 15 (44.1) | 1.00 |
Oral steroid or antibiotic use in last 2 months, Yes (%) | 0 (0) | 0 (0) | 0 (0) | Â |
Adenocarcinoma, Yes (%)c | 5 (62.5) | 21 (58.3) | 26 (59.1) | 1.00 |
Squamous cell carcinoma, Yes (%)c | 1 (12.5) | 9 (25) | 10 (22.7) | 0.659 |
Large cell neuroendocrine tumor, Yes (%) | 0 (0) | 2 (5.6) | 2 (4.5) | 1.00 |
Metastatic colorectal adenocarcinoma, Yes (%) | 1 (12.5) | 0 (0) | 1 (2.3) | 0.182 |
Unidentified carcinoma, Yes (%) | 0 (0) | 1 (2.8) | 1 (2.3) | 1.00 |
No evidence of malignancy, Yes (%) | 1 (12.5) | 2 (5.6) | 3 (6.8) | 0.461 |
No pathologic diagnosis, Yes (%) | 0 (0) | 2 (5.6) | 2 (4.5) | 1.00 |